Sign in

CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company

Silence Therapeutics plc

Sign in to watch
Tickers
SLN SLNCF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
operating
Phone
44-0-20-3457 6900
Business address
12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP

Securities

  • SLN American Depository Share Nasdaq
  • SLNCF Common stock OTC
  1. 8-K Event Results of operations · Regulation FD disclosure
  2. 4 Derivatives Options or other derivatives
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Regulation FD disclosure

Page 6 of 14 · 278 filings